Avalo Therapeutics, Inc. (AVTX)
19.59
-0.46
(-2.29%)
USD |
NASDAQ |
Aug 28, 16:00
19.60
+0.01
(+0.05%)
After-Hours: 20:00
Avalo Therapeutics 30-Day Average Daily Volume : 758515.2 for Aug. 28, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 28, 2026 | 758515.2 |
| August 27, 2026 | 775403.3 |
| August 26, 2026 | 803703.1 |
| August 25, 2026 | 797171.6 |
| August 24, 2026 | 791681.3 |
| August 21, 2026 | 789674.9 |
| August 20, 2026 | 799107.4 |
| August 19, 2026 | 809299.7 |
| August 18, 2026 | 819219.3 |
| August 17, 2026 | 831682.6 |
| August 14, 2026 | 863955.5 |
| August 13, 2026 | 911549.9 |
| August 12, 2026 | 960530.6 |
| August 11, 2026 | 1.030M |
| August 10, 2026 | 1.059M |
| August 07, 2026 | 1.312M |
| August 06, 2026 | 1.344M |
| August 05, 2026 | 1.367M |
| August 04, 2026 | 1.408M |
| August 03, 2026 | 1.454M |
| July 31, 2026 | 1.649M |
| July 30, 2026 | 1.657M |
| July 29, 2026 | 1.677M |
| July 28, 2026 | 1.683M |
| July 27, 2026 | 1.693M |
| Date | Value |
|---|---|
| July 24, 2026 | 1.681M |
| July 23, 2026 | 1.709M |
| July 22, 2026 | 1.735M |
| July 21, 2026 | 1.747M |
| July 20, 2026 | 1.769M |
| July 17, 2026 | 1.791M |
| July 16, 2026 | 1.833M |
| July 15, 2026 | 1.844M |
| July 14, 2026 | 1.851M |
| July 13, 2026 | 1.858M |
| July 10, 2026 | 1.893M |
| July 09, 2026 | 1.897M |
| July 08, 2026 | 1.910M |
| July 07, 2026 | 1.910M |
| July 06, 2026 | 1.908M |
| July 02, 2026 | 1.898M |
| July 01, 2026 | 1.893M |
| June 30, 2026 | 1.916M |
| June 29, 2026 | 1.887M |
| June 26, 2026 | 1.891M |
| June 25, 2026 | 1.657M |
| June 24, 2026 | 1.658M |
| June 23, 2026 | 1.711M |
| June 22, 2026 | 1.705M |
| June 18, 2026 | 1.811M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.636M |
| Incyte Corp. | 1.625M |
| AbbVie, Inc. | 5.008M |
| Rezolute, Inc. | 1.348M |
| Alnylam Pharmaceuticals, Inc. | 2.050M |